Press release
Transforming the Tepezza Market in 2025: Increasing Incidence Of Thyroid Diseases Driving Market Growth
Tepezza Market Size
Over recent years, the market size for Tepezza has risen by $XX (CAGR). It is projected to see an increase from $XX million in 2024 to $XX million in 2025, boasting a compound annual growth rate (CAGR) of $XX%. This historical growth can be credited to factors such as the escalating rates of thyroid eye disease, FDA approval for TED treatments, the scarcity of existing treatment options for TED, a high unsatisfied need for efficient therapies, advancements in the development of biologic drugs, and a rise in the awareness and diagnosis of TED._x000D_
_x000D_
In the coming years, the market size for Tepezza is projected to experience a forward compound annual growth rate (CAGR) of $XX%. By 2029, this market is estimated to expand to a worth of $XX million with a compound annual growth rate (CAGR) of $XX%. The rise during the forecast period could be due to factors such as the escalating aging population, penetration into fresh territorial markets, increasing occurrence of thyroid illnesses, advancements in tailor-made medicine, and the rising adoption of biologic treatments. The forecast period is expected to be characterized by significant trends such as a shift towards care at home, the creation of alternate administration routes, increased usage of combined therapies for TED, a growing emphasis on precision treatment, and the incorporation of artificial intelligence in treatment design._x000D_
_x000D_
What Key Elements Are Boosting Growth in the Tepezza Market?_x000D_
The rise in thyroid disease cases is anticipated to boost the tepezza market's growth in the future. Thyroid diseases encompass a variety of disorders that influence the structure or functionality of the butterfly-shaped thyroid gland in the neck. The frequency of these diseases is on the rise due to factors like advanced diagnostic methods, such as high-resolution ultrasound and fine-needle aspiration, which can identify thyroid abnormalities at an earlier stage. Tepezza (teprotumumab) is typically prescribed for thyroid eye disease because it blocks the insulin-like growth factor-1 receptor (IGF-1R), decreasing inflammation, swelling, and proptosis around the eyes. For example, the National Institutes of Health, a US government agency, projected in July 2022 that thyroid cancer would rank as the 13th most commonly diagnosed cancer in the nation for the year, accounting for about 44,000 new cases or 2.3% of all cancer diagnoses. Hence, the growth of the tepezza market is being driven by the increasing prevalence of thyroid diseases._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=20365&type=smp_x000D_
_x000D_
Who Are the Major Industry Players Fueling Tepezza Market Expansion?_x000D_
Major companies operating in the tepezza market are Amgen Inc. _x000D_
_x000D_
Which Key Developments Are Influencing the Tepezza Market?_x000D_
Obtaining regulatory authorizations to broaden its use beyond Thyroid Eye Disease (TED) appears to be a primary trend in the Tepezza (teprotumumab-trbw) market. Such approvals from health regulatory bodies verify the safety, effectiveness, and quality of a drug for designated medical applications. As a case in point, Horizon Therapeutics plc, a biotech company based in Ireland, revealed in April 2023 that the FDA has sanctioned the modification of TEPEZZA's (teprotumumab-trbw) usage guidelines, thus making it suitable for all TED patients, irrespective of disease activity or duration. This notable shift amplifies treatment availability for all eligible TED patients, as TEPEZZA remains the only FDA-cleared drug exclusively for this disease. The approval validates through data from a Phase 4 clinical study that evidenced TEPEZZA's ability to lessen eye protrusion in patients with long-standing TED. Tim Walbert, CEO of Horizon, pointed out that this amendment aims to enhance early access to treatment, which would eventually benefit patient outcomes._x000D_
_x000D_
How Is the Segmentation of the Tepezza Market Defined?_x000D_
The tepezza market covered in this report is segmented - _x000D_
_x000D_
1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions_x000D_
2) By Route Of Administration: Intravenous; Subcutaneous_x000D_
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies_x000D_
4) By End User: Adult; Geriatric_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/tepezza-global-market-report_x000D_
_x000D_
What Is the Leading Region in the Tepezza Market?_x000D_
North America was the largest region in the tepezza market in 2024. The regions covered in the tepezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Tepezza Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the tepezza Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the tepezza Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall tepezza market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the tepezza market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20365_x000D_
_x000D_
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transforming the Tepezza Market in 2025: Increasing Incidence Of Thyroid Diseases Driving Market Growth here
News-ID: 3875893 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Tepezza
Thyroid Eye Disease Market Poised to Grow at 8.5% CAGR, Reaching USD 3.0 Billion …
Introduction
Thyroid Eye Disease (TED), also known as thyroid-associated ophthalmopathy or orbitopathy, is an autoimmune condition that affects the tissues around the eyes. Closely linked to Graves' disease, TED is characterized by inflammation, swelling, double vision, and in severe cases, sight-threatening complications due to optic nerve compression. The disorder has a profound impact on quality of life, requiring multidisciplinary management by endocrinologists and ophthalmologists.
The global Thyroid Eye Disease (TED) Market is…
Graves' Disease Market New Product Development & Latest Trends
Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the most common thyroid-related autoimmune conditions, disproportionately affecting women between 30-60 years of age. Beyond metabolic complications such as weight loss, heat intolerance, and palpitations, Graves' disease can cause thyroid eye disease (TED), which impairs vision and quality of life.
For decades, treatment has relied on antithyroid…
Tepezza Market Report 2025-2034: Industry Overview, Drivers, And Forecast Analys …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Tepezza Market Size and Its Estimated Growth Rate?
In recent years, the market size for Tepezza has experienced an XX (HCAGR). There's an expected growth from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. Several factors can be…
Increasing Incidence Of Thyroid Diseases Driving Market Growth: A Key Factor Sha …
Which drivers are expected to have the greatest impact on the over the tepezza market's growth?
The increasing incidence of thyroid diseases is expected to fuel the growth of the Tepezza market. Thyroid diseases are rising due to improvements in diagnostic techniques, allowing for earlier detection. Tepezza treats thyroid eye disease by reducing inflammation and swelling around the eyes. For example, in July 2022, the NIH projected 44,000 new cases of…
Graves Ophthalmopathy Market to Expand Significantly by 2034, States DelveInsigh …
The Key Graves Ophthalmopathy Companies in the market include - Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, and others.
The Graves Ophthalmopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves Ophthalmopathy pipeline products will…
Graves' Ophthalmopathy Therapeutics Market Size was ~USD 2,600 million in 2023, …
DelveInsight's "Graves Ophthalmopathy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well as the Graves Ophthalmopathy market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Graves Ophthalmopathy Market with DelveInsight's In-Depth Report @ Graves Ophthalmopathy Market Size- https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from…
